Literature DB >> 22624281

Managing complications in acute myocardial infarction.

Ajit S Mullasari1, P Balaji, Tenzing Khando.   

Abstract

Acute myocardial infarction (AMI) due to coronary artery disease is a leading cause of death in both the developed and developing countries. The advent of coronary care units and early reperfusion therapy (Thrombolytic and Percutaneous Coronary Intervention) has substantially decreased in-hospital mortality rates and has improved the outcome in survivors of the acute phase of MI. Complications of AMI include mechanical, arrhythmic, ischemic, and inflammatory (early pericarditis and post-MI syndrome) sequelae, as well as left ventricular mural thrombus. In addition to these broad categories, right ventricular (RV) infarction and cardiogenic shock are other common complications of AMI. The onset of each of these complications usually results in explicit symptoms and physical manifestations. Thus, a basic knowledge of the complications that occur in the postinfarction period and the clinical syndromes associated with each, will allow the physician to evaluate and treat the complication appropriately.

Entities:  

Mesh:

Year:  2011        PMID: 22624281

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  6 in total

Review 1.  Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India.

Authors:  Santanu Guha; Rishi Sethi; Saumitra Ray; Vinay K Bahl; S Shanmugasundaram; Prafula Kerkar; Sivasubramanian Ramakrishnan; Rakesh Yadav; Gaurav Chaudhary; Aditya Kapoor; Ajay Mahajan; Ajay Kumar Sinha; Ajit Mullasari; Akshyaya Pradhan; Amal Kumar Banerjee; B P Singh; J Balachander; Brian Pinto; C N Manjunath; Chandrashekhar Makhale; Debabrata Roy; Dhiman Kahali; Geevar Zachariah; G S Wander; H C Kalita; H K Chopra; A Jabir; JagMohan Tharakan; Justin Paul; K Venogopal; K B Baksi; Kajal Ganguly; Kewal C Goswami; M Somasundaram; M K Chhetri; M S Hiremath; M S Ravi; Mrinal Kanti Das; N N Khanna; P B Jayagopal; P K Asokan; P K Deb; P P Mohanan; Praveen Chandra; Col R Girish; O Rabindra Nath; Rakesh Gupta; C Raghu; Sameer Dani; Sandeep Bansal; Sanjay Tyagi; Satyanarayan Routray; Satyendra Tewari; Sarat Chandra; Shishu Shankar Mishra; Sibananda Datta; S S Chaterjee; Soumitra Kumar; Soura Mookerjee; Suma M Victor; Sundeep Mishra; Thomas Alexander; Umesh Chandra Samal; Vijay Trehan
Journal:  Indian Heart J       Date:  2017-03-23

2.  LncRNA XIST facilitates hypoxia-induced myocardial cell injury through targeting miR-191-5p/TRAF3 axis.

Authors:  Yonghong Wang; Yanfei Liu; Aike Fei; Zaixin Yu
Journal:  Mol Cell Biochem       Date:  2022-03-07       Impact factor: 3.396

3.  Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis.

Authors:  Changzai Liang; Shen Wang; Meng Zhang; Tianzhu Li
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

Review 4.  Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis.

Authors:  Xiao-Dong Ye; Yi He; Sheng Wang; Gordon T Wong; Michael G Irwin; Zhengyuan Xia
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

Review 5.  Can Saliva Proteins Be Used to Predict the Onset of Acute Myocardial Infarction among High-Risk Patients?

Authors:  Mohd Aizat Abdul Rahim; Zubaidah Haji Abdul Rahim; Wan Azman Wan Ahmad; Onn Haji Hashim
Journal:  Int J Med Sci       Date:  2015-04-03       Impact factor: 3.738

6.  Association between PM2.5 and risk of hospitalization for myocardial infarction: a systematic review and a meta-analysis.

Authors:  Zeynab Farhadi; Hasan Abulghasem Gorgi; Hosein Shabaninejad; Mouloud Aghajani Delavar; Sogand Torani
Journal:  BMC Public Health       Date:  2020-03-12       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.